Oscar Health, Inc. (OSCR)
Oscar Health, Inc. (OSCR) Q2 2026 Earnings Call Transcript
Oscar Health, Inc. (OSCR) Q2 2026 Earnings Call Transcript
Oscar Health (OSCR) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Oscar Health (OSCR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Oscar Health, Inc. (OSCR) Q2 Earnings Beat Estimates
Oscar Health, Inc. (OSCR) came out with quarterly earnings of $1.1 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to a loss of $0.89 per share a year ago.
Oscar Health Reports Another Big Profit As Obamacare Member Costs Ease
Health insurer Oscar Health swung to a $361 million second quarter profit while eclipsing $1 billion in net income for the first six months of the year as health plan membership rose and medical costs eased.
Best Growth Stocks to Buy for August 6th
SANM, OSCR and PENN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 6th, 2026.
Oscar Health, Inc. (OSCR) Reports Next Week: Wall Street Expects Earnings Growth
Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Today
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $30.57, marking a -2.64% move from the previous day.
Oscar Health, Inc. (OSCR) Recently Broke Out Above the 20-Day Moving Average
Oscar Health, Inc. (OSCR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, OSCR broke through the 20-day moving average, which suggests a short-term bullish trend.
Oscar Health: Scale Is Finally Showing Up On The Bottom-Line
Oscar Health has surged over 100% since April, dramatically outperforming the benchmark. Despite the rally, OSCR trades at about a forward P/S of 0.50, suggesting over 80% undervaluation versus the sector median. I maintain my Buy rating, anchored by continued revenue growth, margin expansion, and accelerating bottom-line performance.
Oscar Health, Inc. (OSCR) Registers a Bigger Fall Than the Market: Important Facts to Note
Oscar Health, Inc. (OSCR) reached $29.5 at the closing of the latest trading day, reflecting a -4.13% change compared to its last close.
Oscar Health: Strong Numbers Forced Re-Rating, Now Pay Attention To Continuous Execution
Oscar Health has rerated to the $30 range, reflecting its strong performance but reduced asymmetry versus prior opportunities. Risk Adjustment Transfer dynamics and plan mix will pressure EPS and margins in Q2 and beyond, despite an encouraging Q1 medical loss ratio. I expect MLR to rise to the mid-to-high seventies and negative EPS for upcoming quarters, with SG&A likely flat as tech efficiencies are offset.
Why Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value Investors
Oscar Health (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
